Cargando…
Role of nab-paclitaxel in metastatic breast cancer: a meta-analysis of randomized clinical trials
Whether nab-paclitaxel and conventional taxanes are equally effective for metastatic breast cancer (MBC) remains unclear. We conducted meta-analysis of trials that compared nab-paclitaxel-based chemotherapy with solvent-based paclitaxel (sb-paclitaxel) and docetaxel-based chemotherapy. A literature...
Autores principales: | Liu, Yun, Ye, Guoxin, Yan, Dali, Zhang, Lei, Fan, Fan, Feng, Jifeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5641182/ https://www.ncbi.nlm.nih.gov/pubmed/29069839 http://dx.doi.org/10.18632/oncotarget.18900 |
Ejemplares similares
-
Meta-analysis of gemcitabine plus nab-paclitaxel combined with targeted agents in the treatment of metastatic pancreatic cancer
por: Li, Zhong-Hui, et al.
Publicado: (2022) -
Is nab-paclitaxel better than conventional taxanes as neoadjuvant
therapy for breast cancer? A meta-analysis
por: Li, Yong, et al.
Publicado: (2020) -
Prognostic value of lncRNAs in lung carcinoma: a meta-analysis
por: Fan, Fan, et al.
Publicado: (2017) -
Efficacy and Safety of Platinum-Based Chemotherapy as First-Line Therapy for Metastatic Triple-Negative Breast Cancer: A Meta-Analysis of Randomized Controlled Trials
por: Lu, Fei, et al.
Publicado: (2021) -
The addition of bevacizumab in the first-line treatment for metastatic colorectal cancer: an updated meta-analysis of randomized trials
por: Jang, Hyun Joo, et al.
Publicado: (2017)